Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries

For more information on this project, please contact the EU PE&PV research network at eupepv@uu.nl.

Project information

  • EU PE&PV research network 
  • Specific Contract 01 implementing Framework service contract EMA/2020/46/TDA/L5.06 

Full title

Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen (CoVE) 

Principal investigator

Dr. Elisa Mart铆n Merino, Agencia Espa帽ola de Medicamentos y Productos Sanitarios (AEMPS)

Participating organisations

  • Utrecht 木瓜福利影视, The Netherlands - consortium lead
  • AEMPS, Spain - coordinator
  • UMC Utrecht, The Netherlands 
  • VAC4EU, Belgium
  • Democritus 木瓜福利影视 of Thrace, Greece 
  • APHP, France  
  • ARS, Italy 
  • INSPIRE, Italy 
  • SoSeTe-Pedianet, Italy 
  • R墨ga Stradi艈拧 木瓜福利影视, Latvia 
  • PHARMO Institute, The Netherlands 
  • RIVM, The Netherlands 
  • IACS, Spain
  • IDIAPJGol, Spain  
  • RTI Health Solutions, Spain
  • Servicio Navarro de Salud, Spain 
  • Teamit Institute, Spain 
  • DSRU, UK

Status

Completed (2023)

Deliverables

Peer-reviewed scientific publications

. Riefolo F, Castillo-Cano B, Mart铆n-P茅rez M, Messina D, Elbers R, Brink-Kwakkel D, Villalobos F, Ingrasciotta Y, Garcia-Poza P, Swart-Polinder K, Souverein P, Saiz LC, Bissacco CA, Leache L, Tari M, Crisafulli S, Grimaldi L, Vaz T, Gini R, Klungel O, Mart铆n-Merino E. Vaccine. 2023 Nov 13;41(47):7007-7018. doi: 10.1016/j.vaccine.2023.10.011. Epub 2023 Oct 17. PMID: 37858451.